| HRB(+) n = 21 | HRB(−) n = 25 | p Value | |
| Age (years) | 69.9 (7.8) | 69.6 (7.1) | 0.733 |
| Gender (men/women) | 12/9 | 7/18 | 0.046 |
| Systemic hypertension | 12 | 13 | 0.897 |
| LogMAR VA at initial visit | 0.40 (0.34) | 0.55 (0.35) | 0.092 |
| Foveal thickness at initial visit (μm) | 466 (129) | 516 (165) | 0.453 |
| Duration of symptoms before first treatment (months) | 3.0 (1.7) | 4.4 (3.6) | 0.309 |
| LogMAR VA at final visit | 0.05 (0.13) | 0.32 (0.29) | <0.001 |
| Foveal thickness at final visit (μm) | 198 (32) | 182 (32) | 0.082 |
| Duration of follow-up (months) | 25.9 (19.7) | 20.8 (14.8) | 0.326 |
| Duration of persistent MO (months) | 10.4 (5.5) | 15.0 (11.9) | 0.078 |
HRB, high reflectance band; HRB(+), eyes with third HRB in the fovea; HRB(−), eyes without third HRB; logMAR, logarithm of the minimum angle of resolution; VA, visual acuity; MO, macular oedema.